Elysium Hope

Elysium Hope sells a tightly curated line of longevity-focused dietary supplements and at-home biomarker test kits, all positioned in the premium price tier (single formulas US $60–120, multi-month stacks >$300). Orders are placed only through the brand’s own e-commerce site, which ships worldwide from U.S. and EU fulfillment hubs; no retail or marketplace distribution is used. The company’s distinction is its link to the MIT lab that discovered nicotinamide riboside as a NAD+ precursor; Elysium licenses that IP and uses it as the anchor of its flagship “Basis” cellular-health capsule. Every batch is NSF-certified, and the brand funds peer-reviewed human studies that are published in Nature Partner Journals, a rarity in the supplement space. Customers are 35- to 65-year-old professionals who track sleep, VO2 max, and epigenetic age and are willing to pay for evidence-based interventions rather than generic multivitamins. The brand speaks to the quantified-self ethos: science first, longevity as an attainable goal, and transparency via public COAs and anonymized data summaries. Elysium Hope competes in the high-end “nutraceuticals-for-aging” segment against other biotech-backed pill and testing brands. It differentiates by coupling patented molecules with in-house clinical trials, presenting results in plain language, and offering an optional subscription that pairs supplements with repeat biomarker panels to demonstrate measurable change over time.